Bank of America Begins Coverage on Legend Biotech (NASDAQ:AMTI)

Bank of America started coverage on shares of Legend Biotech (NASDAQ:AMTI) in a research report released on Tuesday, BenzingaRatingsTable reports. The firm issued a buy rating and a $34.00 price objective on the stock.

AMTI stock opened at $27.00 on Tuesday. Legend Biotech has a 52 week low of $17.05 and a 52 week high of $31.84.

About Legend Biotech

Applied Molecular Transport Inc develops biological therapeutics to treat autoimmune, metabolic, and inflammatory diseases.. The company develops submucosal biopharmaceuticals and bio-betters. Applied Molecular Transport Inc was incorporated in 2010 and is based in South San Francisco, California.

See Also: Accumulation/Distribution

Receive News & Ratings for Legend Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Legend Biotech and related companies with's FREE daily email newsletter.